Penumbra (PEN) Common Equity (2014 - 2026)
Penumbra's (PEN) quarterly Common Equity came in at $1.5 billion in Q1 2026, up 21.51% year-on-year from $1.2 billion in Q1 2025, and up 3.24% on a QoQ basis from $1.4 billion in Q4 2025.
Penumbra (PEN) Common Equity (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Common Equity data on file, last reported at $1.5 billion in Q1 2026.
- On a quarterly basis, Common Equity rose 21.51% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 21.51% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 24.04% from the prior year.
- Common Equity for Q1 2026 stood at $1.5 billion, up from $1.4 billion in the prior quarter.
- Over the last five years, Common Equity for PEN reached as high as $1.5 billion in Q1 2026 and fell as low as $959.3 million in Q1 2022.
- Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
- Across the five-year window, Common Equity soared 47.48% in 2022 and slipped 2.38% in 2024, its largest moves.
- Year by year, Common Equity stood at $998.9 million in 2022, then climbed by 18.03% to $1.2 billion in 2023, then slipped by 2.38% to $1.2 billion in 2024, then grew by 24.04% to $1.4 billion in 2025, then grew by 3.24% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $1.5 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Bn |
| Dec 31, 2025 | 1.43 Bn |
| Sep 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 998.86 Mn |
| Sep 30, 2022 | 973.75 Mn |
| Jun 30, 2022 | 970.02 Mn |
| Mar 31, 2022 | 959.30 Mn |
| Dec 31, 2021 | 953.93 Mn |
| Sep 30, 2021 | 684.60 Mn |
| Jun 30, 2021 | 673.38 Mn |